Home > Healthcare > Medical Devices > Diagnostic Devices > Microbiology Testing Market

Microbiology Testing Market - By Product (Instruments, Reagents), By Test Type (Bacterial, Viral, Fungal), By Application (Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections), By End-use & Forecast, 2023 – 2032

  • Report ID: GMI5821
  • Published Date: May 2023
  • Report Format: PDF

Microbiology Testing Market Size

Microbiology Testing Market size was valued at around USD 4.9 billion in 2022 and is projected to reach over USD 11.9 billion by the end of 2032 owing to increasing prevalence of infectious diseases and outbreak of pandemics coupled with technological advancements in microbiology testing products.
 

Microbiology Testing Market

Additionally, supportive government initiatives and rising healthcare expenditure has fueled the demand for screening of several ailments including infectious, bacterial, and fungal diseases. Developing healthcare expenditure, rising private-public funding for research on infectious diseases, growing disposable income are some of the major factors responsible for increased adoption of microbiology testing across the world.
 

Microbiology testing are laboratory analysis of samples to identify and diagnose infectious diseases caused by microorganisms such as bacteria, viruses, fungi, and parasites. These testing are intended to manage chronic diseases, implementing appropriate infection control measures, and optimizing patient care.
 

ede the market growth in the coming years. Limited availability of resources and lack of formal training programs focused on microbiology testing instruments to acquire the necessary skills is anticipated to impede the market progress. Additionally, evolving technological advancements by introducing new features and techniques in microbiology testing can pose a challenge among healthcare professionals in frequent adoption of these techniques and instruments.
 

COVID-19 Impact

The recent outbreak of COVID-19 had positively influenced the microbiology testing market revenue surge, specifically during 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during initial phase of 2020. These conditions positively impacted the market expansion. The urgent need for widespread and accurate testing during the pandemic prompted rapid advancements in microbiology testing technology. Additionally, development of more efficient, sensitive, and faster testing methods, such as PCR-based tests, point-of-care tests, and high-throughput testing platforms have significantly surged the market demand.
 

Microbiology Testing Market Trends

Rising incidence of infectious diseases and outbreaks of epidemics have increased the demand for microbiology testing across the globe. The accurate and timely detection of pathogens, monitoring of resistance patterns, and implementation of appropriate control measures are vital for mitigating the impact of these diseases on public health. Outbreak of infectious diseases, such as COVID-19, influenza, and Ebola among others have increased the product adoption for early detection, diagnosis, and containment of the disease. Microbiology testing helps identify the causative pathogens, track their spread, and implement appropriate public health measures to control the outbreak. Microbiology testing plays a critical role in guiding appropriate antimicrobial therapy optimizing treatment outcomes and reducing the development of antimicrobial resistance.  
 

Microbiology Testing Market Analysis

Global Microbiology Testing Market Size, By Product,

Based on product, the microbiology testing market is segmented as instruments and reagents. Instruments dominated the microbiology testing market in 2022 accounting for more than 63% of the total business share. The instruments segment is poised to highlight substantial growth rate due to factors such as technological advancements, expanded testing volume, rapid and accurate result among others. Rising demand for instruments that offer automation and high-throughput capabilities to process a large number of samples in a shorter time frame, thereby improving efficiency and productivity in microbiology testing.
 

Moreover, rapid detection and analysis of pathogens, such as PCR machines, real-time PCR systems, next-generation sequencing platforms, and automated microbial identification systems, is expected to increase the product demand in several healthcare facilities.
 

Based on test type, the microbiology testing market is segmented as bacterial, viral, and fungal. The bacterial segment held a dominant market revenue of USD 2 billion in 2022. This high market share is owing to several clinical benefits offered by microbiology testing in the detection and diagnosis of bacterial disorders. E. coli bacteria is one of the common cause of Urinary tract infections. Therefore, clinical benefits offered by microbiology testing in diagnosis and treatment of bacterial infection is anticipated to fuel the market outlook.
 

Based on application, the microbiology testing market is segmented as respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and others. The respiratory diseases segment is forecasted to grow at 9% CAGR by 2032. The demand for microbiology testing in respiratory diseases has significantly increased, particularly due to the COVID-19 pandemic and the need to identify and manage other respiratory ailments.
 

Additionally, enhanced efficiency and accuracy in identification of other respiratory ailments such as pneumonia, tuberculosis, pertussis, influenza, respiratory syncytial virus (RSV), etc. have increased the product adoption in several healthcare facilities globally. Microbiology testing enables identification of drug-resistant strains, determine the efficacy of vaccines, control outbreaks and conduct research and public health monitoring.
 

Global Microbiology Testing Market Share, By End-use,

Based on end-use, the microbiology testing market is segmented as hospitals, diagnostic centers, ambulatory surgical centers, and others. The hospital segment is projected to grow at 9.3% CAGR from 2023-2032. This high market share is owing to the availability of advanced microbiology testing instruments and kits for the diagnosis and treatment of varied chronic ailments. Enhanced operability and accessibility to comprehensive range of tests is expected to drive the market growth. Routine blood check-ups, sample tests, and other common diagnostic tests can be easily availed at such hospitals thus, proving beneficial for the industry progression.
 

Additionally, incorporation of advance microbiology instruments coupled with rising healthcare expenditure in several countries will increase the product adoption rate. Owing to these developments along with the rising number of diseases population, the demand for microbiology testing has significantly increased in hospitals. Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of chronic disorders will boost patient visits to hospitals.
 

 Global Microbiology Testing Market Share, By End-use,

The U.S. microbiology testing market is predicted to reach around USD 4.4 billion by 2032. This market share is attributable to numerous variables including the presence of key market players, an increase in the number of chronic diseases, and rising awareness regarding the benefits of microbiology testing for diagnosis and treatment of infectious diseases among others. For instance, according to the American Gastroenterological Association report, in 2021, around 60 million people in America were suffering from gastrointestinal (GI) diseases and is expected to increase in the near future.
 

Microbiology testing equipment help in identifying the epidemiology of these disorders and provide accurate result to healthcare professionals in designing and monitoring plan of action and course of treatment. The higher incidence of these diseases has resulted in the surged number of disease screening procedures that is anticipated to fuel the product adoption rate thereby, further accelerating the business trends.
 

Microbiology Testing Market Share

Some of the major players operating in the microbiology testing market are

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Biomerieux SA
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Danaher Corporation (Cepheid Inc.)
  • F. Hoffmann-La Roche Ltd
  • Hologic Corporation
  • Merck KGaA
  • NEOGEN Corporation
  • QIAGEN
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Microbiology Testing Industry News:

  • In November 2022, IDEXX, announced the acquisition of Tecta-PDS a manufacturer and provider of innovative microbiology testing solutions. Tecta-PDS introduced automation to water microbiology testing for parameters including E. coli and total coliforms. This acquisition helped the company to enhance their product portfolio and increase their business revenue.
     
  • In February 2019, bioMérieux, announced the acquisition of Invisible Sentinel Inc. a manufacture of innovative and user-friendly molecular diagnostic tools for the rapid, detection of pathogens and organisms. This strategic acquisition helped the company to strengthen their microbiology testing segment and increase their customer base.
     

Microbiology testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and Units from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report


By Product, 2018 - 2032 (USD Million & Units)

  • Instruments
  • Reagents

By Test Type, 2018 - 2032 (USD Million)

  • Bacterial
  • Viral
  • Fungal

By Application, 2018 - 2032 (USD Million)

  • Respiratory Diseases
  • Bloodstream Infection
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Others

By End-use, 2018 - 2032 (USD Million)

  • Hospitals
  • Diagnostic Centers
  • Academic and Research Institutes
  • Others  

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Poland
    • Sweden
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Egypt
    • Turkey

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for microbiology testing was worth around USD 4.9 billion in 2022 and is estimated to amass more than USD 11.9 billion by 2032 owing to the outbreak of pandemics, coupled with technological advancements in microbiology testing products.

Instruments accounted for more than 63% of the microbiology testing market revenue in 2022 and are set to record significant growth in adoption driven by several factors such as technological advancements, expanded testing volume, and rapid and accurate results, among others.

The U.S. market size is estimated to reach USD 4.4 billion by the end of 2032 owing to the presence of key market players and an increase in the occurrences of chronic diseases.

The microbiology testing industry consists of top companies such as Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation (Cepheid Inc.), F. Hoffmann-La Roche Ltd, Hologic Corporation, Merck KGaA, NEOGEN Corporation, QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others.

Microbiology Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 451
  • Countries covered: 30
  • Pages: 190
 Download PDF